Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3134394252;94253;94254 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
N2AB2970289329;89330;89331 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
N2A2877586548;86549;86550 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
N2B2227867057;67058;67059 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
Novex-12240367432;67433;67434 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
Novex-22247067633;67634;67635 chr2:178547599;178547598;178547597chr2:179412326;179412325;179412324
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAT
  • RefSeq wild type template codon: TTA
  • Domain: Fn3-116
  • Domain position: 36
  • Structural Position: 37
  • Q(SASA): 0.1852
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/D None None 0.999 N 0.578 0.486 0.300784259202 gnomAD-4.0.0 1.59111E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85799E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.7837 likely_pathogenic 0.7246 pathogenic -1.303 Destabilizing 1.0 D 0.779 deleterious None None None None N
N/C 0.5689 likely_pathogenic 0.5407 ambiguous -0.848 Destabilizing 1.0 D 0.84 deleterious None None None None N
N/D 0.8264 likely_pathogenic 0.7619 pathogenic -1.977 Destabilizing 0.999 D 0.578 neutral N 0.481408417 None None N
N/E 0.9822 likely_pathogenic 0.9726 pathogenic -1.808 Destabilizing 0.999 D 0.658 neutral None None None None N
N/F 0.9832 likely_pathogenic 0.9803 pathogenic -1.087 Destabilizing 1.0 D 0.876 deleterious None None None None N
N/G 0.5863 likely_pathogenic 0.465 ambiguous -1.62 Destabilizing 0.999 D 0.537 neutral None None None None N
N/H 0.4646 ambiguous 0.3874 ambiguous -1.106 Destabilizing 1.0 D 0.679 prob.neutral N 0.502261343 None None N
N/I 0.9787 likely_pathogenic 0.9802 pathogenic -0.477 Destabilizing 1.0 D 0.885 deleterious N 0.505134986 None None N
N/K 0.9745 likely_pathogenic 0.9632 pathogenic -0.439 Destabilizing 1.0 D 0.688 prob.neutral N 0.465061681 None None N
N/L 0.9433 likely_pathogenic 0.9331 pathogenic -0.477 Destabilizing 1.0 D 0.849 deleterious None None None None N
N/M 0.9649 likely_pathogenic 0.9606 pathogenic -0.197 Destabilizing 1.0 D 0.828 deleterious None None None None N
N/P 0.9952 likely_pathogenic 0.9952 pathogenic -0.728 Destabilizing 1.0 D 0.871 deleterious None None None None N
N/Q 0.9352 likely_pathogenic 0.9047 pathogenic -1.271 Destabilizing 1.0 D 0.694 prob.neutral None None None None N
N/R 0.9374 likely_pathogenic 0.914 pathogenic -0.333 Destabilizing 1.0 D 0.698 prob.neutral None None None None N
N/S 0.1628 likely_benign 0.1414 benign -1.316 Destabilizing 0.999 D 0.543 neutral N 0.508416524 None None N
N/T 0.7925 likely_pathogenic 0.7673 pathogenic -0.981 Destabilizing 0.999 D 0.645 neutral N 0.485763283 None None N
N/V 0.9536 likely_pathogenic 0.9534 pathogenic -0.728 Destabilizing 1.0 D 0.875 deleterious None None None None N
N/W 0.9911 likely_pathogenic 0.9894 pathogenic -0.892 Destabilizing 1.0 D 0.811 deleterious None None None None N
N/Y 0.8123 likely_pathogenic 0.7911 pathogenic -0.587 Destabilizing 1.0 D 0.862 deleterious N 0.469153512 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.